How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,145 results for

E/M Established Outpatient Visit

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Obesity Prevention and Management

with a body mass index (BMI) in the past 6 months or during the current visit documented in the medical record. (ACO, MU) Adult: Follow-up plan. If the most recent BMI is outside parameters, a follow-up plan is documented. Parameters: Age 65 and older BMI greater than or equal to 30 OR < 22; Age 18-64 BMI greater than or equal to 25 OR < 18.5. (ACO, MU) Pediatric: BMI documented. The percentage of patients 2- 17 years of age who had an outpatient visit with a PCP or OB/GYN and who had evidence of BMI (...) Obesity Prevention and Management 1 Quality Department Guidelines for Clinical Care Ambulatory Obesity Guideline Team Team Leader Kelly A Orringer, MD Pediatrics Team Members R Van Harrison, PhD Medical Education Satyen S Nichani, MBBS General Medicine Margaret A Riley, MD Family Medicine Amy E Rothberg, MD Endocrinology Lori E Trudeau, MS, RD Nutrition Services Yvette White, RN, CPNP, MS, MHSA Ambulatory Care Services Initial Release July, 2013 Minor/Interim Revision July, 2016 Ambulatory

2020 University of Michigan Health System

102. Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contrai

FOR DIAGNOSIS AND MANAGEMENT 128 APPENDIX 2: DETAILS METHOD AND RESULTS SECTIONS OF MAIN TEXT 131 APPENDIX 3: EVIDENCE GAPS 229 PTJA07 - Ustekinumab for active ulcerative colitis October 2019 EUnetHTA Joint Action 3 WP4 4 LIST OF TABLES AND FIGURES Tables Table 0.1. UNIFI-I trial of ustekinumab versus placebo: summary of results for outcomes (clinical response, clinical remission, endoscopic healing) at week 8 in the ITT analysis 15 Table 0.2. UNIFI-M trial of ustekinumab versus placebo: summary of results (...) for clinical response, clinical remission and endoscopic healing outcomes at week 8 in the ITT analysis for the full population and BF and NBF groups 80 Table 4.11. UNIFI-M maintenance trial of ustekinumab versus placebo: summary of results for clinical response, clinical remission and endoscopic healing outcomes at week 44 in the ITT analysis for the full population and BF and NBF groups 82 Table 4.12. NMA results for clinical response for NBF patients at induction 85 Table 4.13. NMA results for clinical

2020 EUnetHTA

103. Oral Semaglutide for Type 2 Diabetes: Effectiveness and Value

Spread # 60 Cost (year of event): Foot ulcer $2,026 $3,039 $75,264 $14,565 $60,700 # 70 Cost (event history): Renal Disease $67,666 $101,499 $74,719 $37,172 $37,548 # 93 Cost of Outpatient visit: noninsulin $440 $659 $20,087 $55,958 $35,871 # HbA1c change: Oral Semaglutide -1.482 -0.988 $86,889 $53,769 $33,120 # 80 Mild/Moderate Hypoglycemia (Cycles 2+): Add-on Treatments 0.264 0.396 $51,113 $22,526 $28,587 # 63 Cost (year of event): Hypoglycemia Requiring ED visit $1,237 $1,856 $31,033 $58,048 (...) Oral Semaglutide for Type 2 Diabetes: Effectiveness and Value ©Institute for Clinical and Economic Review, 2019 Oral Semaglutide for Type 2 Diabetes: Effectiveness and Value Final Evidence Report December 9, 2019 Prepared for ©Institute for Clinical and Economic Review, 2019 Page i Final Evidence Report – Oral Semaglutide for Type 2 Diabetes Return to Table of Contents ICER Staff and Consultants University of Washington School of Pharmacy Modeling Group David M. Rind, MD, MSc Chief Medical

2020 California Technology Assessment Forum

104. Curriculum for endoscopic submucosal dissection training in Europe

Western endoscopists who individually visited Japanese expert centers and observed ESD on real pa- tients [3]. However, going to Eastern countries to learn this techniqueis not feasibleformost Western endoscopists.More- over,hands-ontrainingon patientsfor foreignphysiciansis not easily nor legally allowed either in Japan or in other parts of the world. Therefore, there is a clear need for well-organized compre- hensive strategies to achieve good training in ESD. In this con- text, the European Society (...) to Western countries where they are only admitted for 1 – 2 days [68] or even treated as outpatients [69]. Never- theless, it appears that a treatment strategy with at least the possibility of admitting the patient to the hospital is fundamen- tal to forearm a serious adverse event [70]. Moreover, even though most ESD complications can be solved endoscopically, surgery may be needed in almost 1 % of procedures, particular- ly in centers with less experience [71]. For all these reasons, it is our opinion

2020 European Society of Gastrointestinal Endoscopy

105. Undernutrition in Chronic Kidney Disease

outpatient visit, taking account of changes in fluid balance and recent changes in the amount of food being eaten. People with progressive stage 4 CKD are likely to benefit from education from specialist renal dietitians in terms of advice about energy, salt, potassium and phosphate intake even if they do not flag as a concern on nutritional screening tests 15 . We suggest that established patients on dialysis should be screened every 2-3 months. If concerns arise due to intercurrent illness, screening (...) Summary 277 4 1. Introduction Background “ M aln u tri tio n ” describes both over and undernutrition. In the UK, the National Institute for Health and Care Excellence (NICE) define malnutrition as “a state in which a deficiency of nutrients such as energy, protein, vitamins and minerals causes measurable adverse effects on body composition, function or clinical o u tc o m e” in their Clinical Guideline (CG 32) 1 and Quality Standard (QS24) 2 . These guidelines suggest that patients at high risk

2019 Renal Association

106. Addressing unwarranted variation in healthcare

patient-related and non-patient related factors in thoracic aortic disease, predictors of variation in outpatient physician visits, and variation in readmission, mortality, costs and multiple process indicators in acute coronary syndrome patients. 24, 27, 28 Through combining a process of systematic review, process and structure questionnaires of cardiac surgery units and an analysis of hospital episode statistics and cardiac surgery audit data, Bottle et al (2017) 24 determined substantial regional (...) currently organised. 24 Johannsen et al (2018) 27 utilised data from 21 Swedish county councils to understand the degree of regional variation in outpatient physician visits that was explained by demand factors such as health, demography and socioeconomic indicators. Regional mortality, as a proxy for population health, and demography explained around 50% of regional variation in visits to outpatient specialists, but did not explain variation in visits to primary care physicians. Variation in primary

2019 Sax Institute Evidence Check

107. Guidelines For Professional Ultrasound Practice

SCREENING EXAMINATIONS USING ULTRASOUND 19 1.9 ERGONOMIC PRACTICE INCLUDING MANAGING THE HIGH BMI PATIENT 21 1.10 INTIMATE EXAMINATIONS AND CHAPERONES 23 1.11 EXAMINATION TIMES 24 1.12 THE 6 C’s, PATIENT IDENTIFICATION, COMMUNICATION AND CONSENT 25 1.13 CLINICAL GOVERNANCE 27 1.14 E-LEARNING FOR HEALTHCARE 29 1.15 IMAGING SERVICES ACCREDITATION SCHEME (ISAS) 29 1.16 ULTRASOUND EQUIPMENT AND QUALITY ASSURANCE TESTING 30 1.17 RAISING CONCERNS; SAFEGUARDING; STATUTORY REQUIREMENTS FOR REPORTING FEMALE (...) Guidelines for Professional Ultrasound Practice. Revision 3, December 2018 Minor amendments, March 2019. 5 Thanks is also given to J M Bridson and G Johnson of University of Liverpool, and Dr P Rowlands of The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool for their previous work on the document "Clinical Standards and framework for the assessment of initial and ongoing competence of ultrasound practitioners " (BMUS 2011) which forms the foundation for section 2.6

2019 British Medical Ultrasound Society

108. Quiet Hospitals: A Rapid Review

Inclusion/Exclusion Criteria The search strategy for this report can be found in Table 1 in the Appendix. Inclusion/exclusion criteria can also be found in Table 2 in the Appendix. Study Selection Papers identified were screened using inclusion and exclusion criteria established a priori. Searches of Pubmed, and TRIP database were screened by one reviewer (CJ) in consultation with colleagues as necessary. Google search was screened by another reviewer (MG) also, in consultation with colleagues (...) for preventing in-room activity during Naptime. There is concern that day shift caregivers would be frustrated if certain tasks (e.g. bathing) did not occur overnight. There were no adverse effects of the Naptime intervention. Conclusions There were no studies that were found that investigated the impact of overhead paging as a single intervention on patient or staff satisfaction. References 1. Delaney, L., Litton, E., & Van Haren, F. (2019). The effectiveness of noise interventions in the ICU. Current

2019 Monash Health Evidence Reviews

109. NAPBC Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic

outcomes. RESULTS Priority categories and treatment recommendations by specialty are listed below. Outpatient visits During the pandemic, the majority of encounters should be conducted remotely via telemedicine. Decisions to conduct in-person visits must carefully weigh the risk of viral transmission to patients and healthcare providers with the need for an in-person evaluation. Priority A includes, for example, clinically unstable post-operative patients and those with potential medical oncologic (...) : CALGB 40903 (Alliance). J Clin Oncol. 2020:JCO1900510. 41. Masuda N, Iwata H, Rai Y, et al. Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2011;126(2):443-451. 20 42. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97(11):798-804. 43. Chow E, Harris K, Fan G, Tsao M, Sze

2020 American Society for Radiation Oncology

110. Crizanlizumab, Voxelotor, and L-Glutamine for Sickle Cell Disease: Effectiveness and Value

, Spackman E, Synnott PG, Chapman R, Beinfeld M, Rind DM, Pearson SD. Crizanlizumab, Voxelotor, and L-Glutamine for Sickle Cell Disease: Effectiveness and Value. Institute for Clinical and Economic Review, January 23, 2020. https://icer-review.org/material/sickle-cell-disease-draft-evidence-report/ DATE OF PUBLICATION: March 12, 2020 Pamela Bradt served as the lead author for the report. Patricia Synnott led the systematic review and authorship of the comparative clinical effectiveness section (...) on the clinical and economic evaluations. We would also like to thank Foluso Agboola and Monica Frederick for their contributions to this report. ICER Staff University of Calgary Pamela Bradt, MD, MPH Chief Scientific Officer ICER Patricia G. Synnott, MALD, MS Director, Evidence Review ICER Rick Chapman, PhD, MS Director of Health Economics ICER Molly Beinfeld, MPH Research Lead, Evidence Synthesis ICER David M. Rind, MD, MSc Chief Medical Officer ICER Steven D. Pearson, MD, MSc President ICER Eldon Spackman

2020 California Technology Assessment Forum

111. Acute Treatments for Migraine

Review David M. Rind, MD, MSc Chief Medical Officer Institute for Clinical and Economic Review Steven D. Pearson, MD, MSc President Institute for Clinical and Economic Review Daniel R. Touchette, PharmD, MA Professor of Pharmacy Assistant Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research University of Illinois at Chicago Todd A. Lee, PharmD, PhD Professor of Pharmacy Head of Pharmacy Systems, Outcomes, and Policy College of Pharmacy University of Illinois at Chicago *The role (...) of the University of Illinois at Chicago College of Pharmacy’s Center for Pharmacoepidemiology and Pharmacoeconomic Research is limited to the development of the cost-effectiveness model, and the resulting ICER reports do not necessarily represent the views of the UIC. DATE OF PUBLICATION: February 25, 2020 How to cite this document: Atlas S, Touchette D, Agboola F, Lee T, Chapman R, Pearson S D, Rind D M. Acute Treatments for Migraine: Effectiveness and Value. Institute for Clinical and Economic Review

2020 California Technology Assessment Forum

112. Treatment of Depression in Children and Adolescents

International–University of North Carolina at Chapel Hill Evidence-based Practice Center Research Triangle Park, NC Investigators: Meera Viswanathan, Ph.D. Sara M. Kennedy, M.P.H. Joni McKeeman, Ph.D. Robert Christian, M.D. Manny Coker-Schwimmer, M.P.H. Jennifer Cook Middleton, Ph.D. Carla Bann, Ph.D. Linda Lux, M.P.A. Charli Randolph, B.A. Valerie Forman-Hoffman, Ph.D., M.P.H. AHRQ Publication No. 20-EHC005-EF April 2020 ii Key Messages Purpose of Review The purpose of the review is to examine the benefits (...) . Suggested citation: Viswanathan M, Kennedy SM, McKeeman J, Christian R, Coker- Schwimmer M, Cook Middleton J, Bann C, Lux L, Randolph C, Forman-Hoffman V. Treatment of Depression in Children and Adolescents: A Systematic Review. Comparative Effectiveness Review No. 224. (Prepared by the RTI International–University of North Carolina at Chapel Hill Evidence-based Practice Center under Contract No. 290-2015-00011-I.) AHRQ Publication No. 20-EHC005-EF. Rockville, MD: Agency for Healthcare Research

2020 Effective Health Care Program (AHRQ)

113. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

. Providers are encouraged to visit resources such as the newly created website, https://www.covid19-druginteractions.org/ to aid in the evaluation and management of drug interactions with current and emerging investigational agents for COVID-19. Azithromycin is low risk for cytochrome P450 interactions [24]; however additional pharmacologic adverse events including gastrointestinal effects and QT prolongation need to be carefully considered particularly in the outpatient setting where frequent ECG (...) Baden 5 , Vincent Chi-Chung Cheng 6 , Kathryn M. Edwards 7 , Rajesh Gandhi 8 , William J. Muller 9 , John C. O’Horo 10 , Shmuel Shoham 11 , M. Hassan Murad 12 , Reem A. Mustafa 13 , Shahnaz Sultan 14 , Yngve Falck-Ytter 3 Affiliations 1 Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio 2 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario 3 VA Northeast Ohio Healthcare System, Case Western Reserve University School of Medicine

2020 Infectious Diseases Society of America

114. Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care: Diagnosis and Treatment of Low Back Pain

. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient and the needs and resources particular to the locality or institution. 3 Surgical T reatment Section Section Chair: William C. Watters III, MD, MS Authors: Thiru M. Annaswamy, MD Steven W. Hwang, MD Cumhur Kilincer, MD, PhD Richard J. Meagher, MD Anil K. Sharma, MD Kris E. Radcliff, MD; Stakeholder Representative, American Academy (...) the guideline, readers will see many ac- ronyms with which they may not be familiar. A glos- sary of acronyms is available on page 14. N omencla tur e f or M edical/In t erv en tional Treatment Throughout the guideline, readers will see that what has traditionally been referred to as “nonoperative,” “nonsurgical,” or “conservative” care is now referred to as “medical/interventional care.” The term medi- cal/interventional is meant to encompass pharmaco- logical treatment, physical therapy, exercise therapy

2020 American Academy of Pain Medicine

115. Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections Full Text available with Trip Pro

Cardiovascular Institute, Foothills Medical Centre, Calgary, Alberta, Canada , MD c , x Joseph E. Bavaria Affiliations Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pa , MD d , x Adam W. Beck Affiliations Division of Vascular Surgery and Endovascular Therapy, University of Alabama at Birmingham, Birmingham, Ala , MD e , x Richard P. Cambria Affiliations Division of Vascular and Endovascular Surgery, St. Elizabeth's Medical Center, Brighton, Mass , MD f , x (...) Kristofer Charlton-Ouw Affiliations Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center at Houston, Houston, Tex , MD g , x Mohammad H. Eslami Affiliations Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa , MD h , x Karen M. Kim Affiliations Department of Cardiac Surgery, University of Michigan, Ann Arbor, Mich , MD i , x Bradley G. Leshnower Affiliations Division of Cardiothoracic Surgery, Emory University School of Medicine

2020 Society for Vascular Surgery

116. Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic

in my patients? a. Minimize medical facility visits: During this pandemic we recommend that centers minimize medical facility visits by: · All patients: • Seeing only essential patients in clinic and reducing clinic volume by deferring outpatient visits for patients that are clinically well. • Implementation of telemedicine approaches based on telephone or web contact, as locally available, to assess patients and to screen for symptoms consistent with COVID-19. The remote contact should be noted (...) necessary for airway issues in lung transplant recipients, these should be done with appropriate protection for the bronchoscopist as directed by local recommendations and guidance. • For lung transplant patients, in order to minimize exposure to the Pulmonary Function Test (PFT) laboratory personnel we recommend using home spirometry for routine monitoring of lung function rather than performing spirometry in the PFT lab. We recommend incorporation of home spirometry data into virtual outpatient visits

2020 International Society for Heart and Lung Transplantation

117. Guidance on provision of pleural services during the COVID-19 pandemic

of pleural effusion in COVID-19 pandemic *Clinical judgement on a case by case basis as well an assessment of the pre-test probability of successful cytological diagnosis (including local resources e.g. p16 FISH testing) should always dictate choice of diagnostic test Authors: R Hallifax, JM Wrightson, A Bibby, S Walker, A Stanton, D De Fonseka, E Bedawi, A Clive, J Latham, K Blyth, S Jackson, K Marshall, N Maskell, R Bhatnagar, J Corcoran, E Belcher, M Evison, N Rahman, M Munavvar British Thoracic (...) Guidance on provision of pleural services during the COVID-19 pandemic 1 V1.0 3/4/2020 Pleural services during the COVID-19 Pandemic The current COVID-19 pandemic is putting enormous strain on NHS resources. This will cause increasing disruption to established clinical pathways, and in-patient bed shortages. This document aims to provide guidance on the provision of a pleural service during this crisis. The main priorities are to continue to provide diagnostic pathways for suspected cancer

2020 British Thoracic Society

118. The Use of Hysteroscopy for the Diagnosis and Treatment of Intrauterine Pathology

for cervical priming before outpatient hysteroscopy. Fertil Steril 2011;96:962–5. Article Locations: Issat T, Beta J, Nowicka MA, Maciejewski T, Jakimiuk AJ. A randomized, single blind, placebo-controlled trial for the pain reduction during the outpatient hysteroscopy after ketoprofen or intravaginal misoprostol. J Minim Invasive Gynecol 2014;21:921–7. Article Locations: Casadei L, Piccolo E, Manicuti C, Cardinale S, Collamarini M, Piccione E. Role of vaginal estradiol pretreatment combined with vaginal (...) the “no-touch” technique. BJOG 2005;112:963–7. Article Locations: Garbin O, Kutnahorsky R, Gollner JL, Vayssiere C. Vaginoscopic versus conventional approaches to outpatient diagnostic hysteroscopy: a two-centre randomized prospective study. Hum Reprod 2006;21:2996–3000. Article Locations: Sagiv R, Sadan O, Boaz M, Dishi M, Schechter E, Golan A. A new approach to office hysteroscopy compared with traditional hysteroscopy: a randomized controlled trial. Obstet Gynecol 2006;108:387–92. Article Locations

2020 American College of Obstetricians and Gynecologists

119. Chronic Cough Due to Stable Chronic Bronchitis: CHEST Expert Panel Report

iron ore miners. Occup Med (Lond). 2006;56(6):380-385. 21. Holm M, Kim JL, Lillienberg L, et al. Incidence and prevalence of chronic bronchitis: impact of smoking and welding—the RHINE study. Int J Tuberc Lung Dis. 2012;16(4):553-557. 22. Holm M, Torén K, Andersson E. Incidence of chronic bronchitis: a prospective study in a large general population. Int J Tuberc Lung Dis. 2014;18(7):870-875. 23. Jindal SK, Aggarwal AN, Chaudhry K, et al. A multicentric study on epidemiology of chronic obstructive (...) , this article, and the innovation addressed within Q5 . CORRESPONDENCETO: MarkA. Malesker,PharmD,FCCP, Pharmacy Practice Department, Creighton University, 2500 California Plaza, Omaha, NE 68178 Q6 ; e-mail: MarkMalesker@creighton.edu Copyright 2020 AmericanCollegeof ChestPhysicians. Publishedby Elsevier Inc. All rights reserved. DOI:https://doi.org/10.1016/j.chest.2020.02.015 [ Education andClinical Practice Guidelines andConsensusStatements ] chestjournal.org 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

2020 American College of Chest Physicians

120. Chronic Kidney Disease - Identification, Evaluation and Management of Adult Patients

, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J J Assoc Can Radiol. 2014 May;65(2):96–105. Komenda P, Zalunardo N, Burnett S, Love J, Buller C, Taylor P, et al. Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series. Clin Exp Nephrol. 2007 Sep;11(3):209–13. Schachter ME, Romann A, Djurdev O, Levin (...) (ESRD) and other complications The three dimensions of C ause, e G FR and A lbuminuria (CGA) are all important in developing a management plan Prompt advice from local internists, local nephrologists or the RACE Line is available to assist in determining the need for and timing of referral Figure 1. Prognosis and recommendations for frequency of monitoring based on eGFR and uAC * Adapted from and Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline

2019 Clinical Practice Guidelines and Protocols in British Columbia

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>